The prevention of hepatitis in haemodialysis units.
D002353:Carrier State / Q000453:epidemiology; D006509:Hepatitis B / Q000453:epidemiology / Q000517:prevention & control*; D006511:Hepatitis B Antigens / Q000302:isolation & purification; D006801:Humans; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000627:therapeutic use; D008403:Mass Screening; D006435:Renal Dialysis / Q000009:adverse effects*
D006511:Hepatitis B Antigens; D007136:Immunoglobulins